Literature DB >> 22220148

Chlamydophila pneumoniae Infection Induced Nodular Vasculitis.

H Sakuma1, S Niiyama, Y Amoh, K Katsuoka.   

Abstract

We present the case history of a 48-year-old male patient with Chlamydophila (Chlamydia) pneumoniae who developed a nodular vasculitis. He developed a cutaneous vasculitis with the onset of respiratory symptoms. The diagnosis of Chlamydophila pneumoniae infection was based on serology. Since this infection is very common in our population, although often asymptomatic, it should be systematically considered as a causative agent of nodular vasculitis.

Entities:  

Keywords:  Chlamydia pneumoniae; Erythema induratum; Erythema nodosum

Year:  2011        PMID: 22220148      PMCID: PMC3250671          DOI: 10.1159/000335377

Source DB:  PubMed          Journal:  Case Rep Dermatol        ISSN: 1662-6567


Introduction

Erythema nodosum is the most common type of panniculitis; it may be due to a variety of underlying infectious or otherwise antigenic stimuli. Nodular vasculitis (erythema induratum) is a related but distinctly different clinicopathologic reaction pattern of the subcutaneous fat. It is classically caused by an antigenic stimulus from Mycobacterium tuberculosis but may be associated with several other underlying disorders. To our knowledge, there are only a few previous case reports of manifestations of nodular vasculitis in connection with Chlamydophila (Chlamydia) pneumoniae infection.

Case Report

A 48-year-old Japanese man with diabetes mellitus and sleep apnea syndrome presented with skin eruptions on his extremities that he first noticed 2 weeks prior to his admission to our hospital. A week after the appearance of the eruptions, he developed generalized malaise and a further week after that, he developed fever. He was diagnosed as having bacterial pneumonia by another hospital and treated with β-lactam antimicrobial agents, including cefdinir and ceftazidime for about 10 days, but without effect. Thus, he visited the department of internal medicine of our hospital about 5 days before admission to our department. Laboratory data on that day were as follows. Urine Legionella antigen and Streptococcus pneumoniae antigen were negative. Serum Mycoplasma antibody was negative (complement-fixation test). Anti-C. pneumoniae IgA 1.61 C.O.I. (negative <0.90), anti-C. pneumoniae IgG 2.85 C.O.I. (negative <0.90). On admission (day 1), body temperature was 37.4°C, blood pressure was 114/75 mm Hg, and pulse was regular, 101 beats/min. Laboratory results: hemoglobin 11.8 g/dl, WBC count 10 × 103/μl (neutrophil 71.0%), and PLT count 37.6 × 104/μl. CRP 6.87 mg/dl, total bilirubin 0.4 mg/dl, AST 12 IU/l, ALT 9 IU/l, creatinine 0.58 mg/dl, and albumin 3.4 g/dl. ANA and RF were negative. MPO-ANCA and PR3-ANCA were negative. Chest computed tomography (CT) showed interstitial pneumonia and alveolar pneumonia was intermingled. Physical examination revealed crops of tender, violaceous nodules on his extremities, and their sizes ranged from 5 to 10 mm in diameter (fig. ). Histopathological examination shows diffuse septolobular panniculitis of nearby vessels (fig. ). Perivascular infiltrates with neutrophils, extravasation of red blood cells, and fibrinoid degeneration were identified (fig. ). A direct immunofluorescent study showed no immunoglobulin deposition. He was diagnosed with C. pneumoniae infection, and this infection induced nodular vasculitis. From the 2nd to the 17th day, he was treated with pazufloxacin, 1 g daily. The serum CRP fell gradually to become 0.57 mg/dl on the 16th day, and return to normal range by one month. After the 20th day, the indurated erythema began to improve, and seemed to run parallel with the improvement of the serum CRP. We measured it again 40 days after the first time: anti-C. pneumoniae IgA 0.95 C.O.I., anti-C. pneumoniae IgG 3.18 C.O.I.

Discussion

Summarizing the case, our patient presented with the signs/symptoms of pneumonia with an interstitial shadow and an infiltrating shadow on chest CT. Cephems were ineffective, whereas the newer quinolones were effective. Changes in the blood antibody titers in addition to these observations and results suggested C. pneumoniae infection. Nodular vasculitis subsided along with improvement of the pneumonia following antibiotic administration, suggesting that it was caused by C. pneumoniae infection. Several studies showed that C. pneumoniae infection could be involved in the pathogenesis of MPO-ANCA-associated glomerulonephritis, reactive arthritis, SLE, and adult onset of Still's disease [1]. Much less is known about the role of C. pneumoniae in the pathogenesis of systemic diseases. One explanation is molecular mimicry [2]. Immune responses and/or antibodies against it are unknown. C. pneumoniae antigen might cross-react with several body tissues such as the kidney, blood vessels, skin, joint, and muscle. Alternatively, C. pneumoniae can survive and replicate within the epithelial cells, macrophages, and neutrophils. C. pneumoniae-infected cells may then trigger abnormal signal transduction, resulting in changes of the cytokine profiles and activation and/or deactivation of immunocytes such as B cells, T cells, macrophages, and NK cells [3]. Nodular vasculitis has been associated with infectious tuberculosis and/or nontuberculous and noninfectious disorders. Infectious nontuberculous cases have been associated with Nocardia, Pseudomonas, and Fusarium [4]. There may also be an association with hepatitis B virus and hepatitis C virus [5]. Noninfectious associations may include previous episodes of superficial thrombophlebitis of the lower legs, hypothyroidism, chronic lymphocytic leukemia, rheumatoid arthritis, and Crohn's disease [5]. Some reports in the past have shown that all cases of exanthema caused by C. pneumoniae are of the erythema nodosum type [6, 7, 8, 9, 10, 11, 12] (table ). However, the histopathological findings in 3 [6, 11, 12] of the 7 exanthema cases have been reported previously, and these 3 cases showed features of vasculitis. Although omitted in those papers, the other 4 cases may also have been histopathologically found to show findings of vasculitis. It is therefore possible that the eruption reported as erythema nodosum is actually nodular vasculitis.

Disclosure Statement

We have no conflict of interest in relation to the publication of this paper.
Table 1

Review of the literature concerning the association of C. pneumoniae infection with erythema nodosum

Reference numberAge/sexType of infectionAssociated disease(s)Diagnostic criteria of Chlamydophila infectionOther findings
[6]48/FLower respiratoryEpiscleritisCFHistology: vasculitis

[7]17/MLower respiratoryNoneMIF
11/FLower respiratoryNoneMIF

[8]37/MLower respiratoryMyocarditis, reactive arthritisMIF

[9]37/MMeningitisHepatitis, iritisMIFClinical diagnosis: atypical erythema nodosum or vasculitis

[10]Not specifiedLöfgren's syndromeMIF

[11]45/MUpper and lower respiratoryReactive arthritis, conjunctivitisMIFHistology: vasculitis

[12]42/FNoneNoneHistology: infiltrations around the vessels

Present study48/MLower respiratoryNoneHistology: vasculitis

CF = Complement fixation; MIF = micro-immunofluorescence.

  12 in total

1.  Löfgren's syndrome as the first manifestation of acute infection due to Chlamydia pneumoniae: a prospective study.

Authors:  I Marie; F Lecomte; H Levesque; C Janvresse; J M Kerleau; N Cailleux; H Courtois
Journal:  Clin Infect Dis       Date:  1999-03       Impact factor: 9.079

2.  Pneumonia, myocarditis and reactive arthritis due to Chlamydia pneumoniae.

Authors:  J T Gran; R Hjetland; A H Andreassen
Journal:  Scand J Rheumatol       Date:  1993       Impact factor: 3.641

3.  Erythema nodosum caused by ascariasis and Chlamydophila pneumoniae pulmonary infection--a case report.

Authors:  Beata Bergler-Czop; Anna Lis-Swiety; Grazyna Kamińska-Winciorek; Ligia Brzezińska-Wcisło
Journal:  FEMS Immunol Med Microbiol       Date:  2009-08-21

4.  Erythema nodosum in chlamydial infections.

Authors:  M Kousa; P Saikku; L Kanerva
Journal:  Acta Derm Venereol       Date:  1980       Impact factor: 4.437

5.  Erythema nodosum--a manifestation of Chlamydia pneumoniae (strain TWAR) infection.

Authors:  M Erntell; K Ljunggren; T Gadd; K Persson
Journal:  Scand J Infect Dis       Date:  1989

6.  Vasculitis in erythema induratum of Bazin: a histopathologic study of 101 biopsy specimens from 86 patients.

Authors:  Sonia Segura; Ramón M Pujol; Felicidade Trindade; Luis Requena
Journal:  J Am Acad Dermatol       Date:  2008-11       Impact factor: 11.527

7.  Acute Chlamydia pneumoniae infection in the pathogenesis of autoimmune diseases.

Authors:  M Fujita; S Hatachi; M Yagita
Journal:  Lupus       Date:  2009-02       Impact factor: 2.911

8.  An unusual manifestation of Chlamydia pneumoniae infection: meningitis, hepatitis, iritis and atypical erythema nodosum.

Authors:  B Sundelöf; H Gnarpe; J Gnarpe
Journal:  Scand J Infect Dis       Date:  1993

9.  Infection-induced panniculitis.

Authors:  J W Patterson; P C Brown; A H Broecker
Journal:  J Cutan Pathol       Date:  1989-08       Impact factor: 1.587

Review 10.  Molecular mimicry and auto-immunity.

Authors:  Miri Blank; Ori Barzilai; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2007-02       Impact factor: 10.817

View more
  3 in total

1.  Myopathy caused by anoctamin 5 mutations and necrotizing vasculitis.

Authors:  Isabelle Pénisson-Besnier; Jean-Paul Saint-André; Debbie Hicks; Anna Sarkozy; Anne Croué; Judith Hudson; Hanns Lochmüller; Frédéric Dubas
Journal:  J Neurol       Date:  2012-04-19       Impact factor: 4.849

2.  Nodular Vasculitis That Developed during Etanercept (Enbrel) Treatment in a Patient with Psoriasis.

Authors:  Seung-Bae Park; In-Kyu Chang; Myung Im; Young Lee; Chang-Deok Kim; Young-Joon Seo; Jeung-Hoon Lee
Journal:  Ann Dermatol       Date:  2015-10-02       Impact factor: 1.444

3.  Lower-leg Cellulitis-like Manifestations of Erythema Nodosum Induced by Chlamydophila pneumoniae Infection.

Authors:  Takahiro Sawada; Mitsuhiro Suehiro; Kiho Takaya
Journal:  Indian J Dermatol       Date:  2016 Mar-Apr       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.